(Total Views: 679)
Posted On: 10/21/2024 10:49:06 PM
Post# of 153988
2 oral presentations this Wednesday in New Orleans.
Short-term Combination Immunotherapy with bNAbs and CCR5 Blockade Mediates ART-Free Viral Control in Infant Rhesus Macaques, Wednesday, 23rd October - 14:00: (Grand Ballroom (Westin New Orleans)) - Oral
AAV Delivery of the CCR5-blocking monoclonal antibody Leronlimab yields long-term expression and ART-free remission from SHIV viremia, Wednesday, 23rd October - 14:00: (Grand Ballroom (Westin New Orleans)) - Oral
https://www.reddit.com/r/Livimmune/comments/1...y_updates/
Short-term Combination Immunotherapy with bNAbs and CCR5 Blockade Mediates ART-Free Viral Control in Infant Rhesus Macaques, Wednesday, 23rd October - 14:00: (Grand Ballroom (Westin New Orleans)) - Oral
AAV Delivery of the CCR5-blocking monoclonal antibody Leronlimab yields long-term expression and ART-free remission from SHIV viremia, Wednesday, 23rd October - 14:00: (Grand Ballroom (Westin New Orleans)) - Oral
https://www.reddit.com/r/Livimmune/comments/1...y_updates/
(18)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
